Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The United Laboratories International Holdings ( (HK:3933) ) has provided an announcement.
The United Laboratories International Holdings Limited announced a final cash dividend of RMB 0.28 per share for the financial year ending December 31, 2024. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.094945, with a payment date set for July 23, 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited operates in the pharmaceutical industry, focusing on the production and distribution of various pharmaceutical products. The company is known for its commitment to providing high-quality medications and has a significant presence in the market, catering to a wide range of healthcare needs.
YTD Price Performance: 20.23%
Average Trading Volume: 13,263,745
Technical Sentiment Signal: Buy
Current Market Cap: HK$27B
See more insights into 3933 stock on TipRanks’ Stock Analysis page.